Abstract
Structured treatment interruption (STI) may help to alleviate the problems associated with long-term antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected patients. We analyzed the role that baseline levels of cytokines in plasma play as markers of a favorable outcome of STI. Two groups of patients were defined: STI responders and STI nonresponders. STI responders showed a higher baseline concentration of interleukin (IL)-15 in plasma than did STI nonresponders and showed lower levels of tumor necrosis factor (TNF)-α during STI. No differences were observed in levels of IL-2, IL-7, or interferon-α in plasma. Our data show that (1) levels of TNF-α in plasma correlate with HIV viremia and (2) monitoring baseline levels of IL-15 in plasma allows for the identification of a favorable outcome of STI.
| Original language | English |
|---|---|
| Pages (from-to) | 661-665 |
| Number of pages | 5 |
| Journal | Journal of Infectious Diseases |
| Volume | 188 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Sep 1 2003 |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Immunology
Cite this
Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection. / Amicosante, Massimo; Poccia, Fabrizio; Gioia, Cristiana; Montesano, Carla; Topino, Simone; Martini, Federico; Narciso, Pasquale; Pucillo, Leopoldo P.; D'Offizi, Gianpiero.
In: Journal of Infectious Diseases, Vol. 188, No. 5, 01.09.2003, p. 661-665.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection
AU - Amicosante, Massimo
AU - Poccia, Fabrizio
AU - Gioia, Cristiana
AU - Montesano, Carla
AU - Topino, Simone
AU - Martini, Federico
AU - Narciso, Pasquale
AU - Pucillo, Leopoldo P.
AU - D'Offizi, Gianpiero
PY - 2003/9/1
Y1 - 2003/9/1
N2 - Structured treatment interruption (STI) may help to alleviate the problems associated with long-term antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected patients. We analyzed the role that baseline levels of cytokines in plasma play as markers of a favorable outcome of STI. Two groups of patients were defined: STI responders and STI nonresponders. STI responders showed a higher baseline concentration of interleukin (IL)-15 in plasma than did STI nonresponders and showed lower levels of tumor necrosis factor (TNF)-α during STI. No differences were observed in levels of IL-2, IL-7, or interferon-α in plasma. Our data show that (1) levels of TNF-α in plasma correlate with HIV viremia and (2) monitoring baseline levels of IL-15 in plasma allows for the identification of a favorable outcome of STI.
AB - Structured treatment interruption (STI) may help to alleviate the problems associated with long-term antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected patients. We analyzed the role that baseline levels of cytokines in plasma play as markers of a favorable outcome of STI. Two groups of patients were defined: STI responders and STI nonresponders. STI responders showed a higher baseline concentration of interleukin (IL)-15 in plasma than did STI nonresponders and showed lower levels of tumor necrosis factor (TNF)-α during STI. No differences were observed in levels of IL-2, IL-7, or interferon-α in plasma. Our data show that (1) levels of TNF-α in plasma correlate with HIV viremia and (2) monitoring baseline levels of IL-15 in plasma allows for the identification of a favorable outcome of STI.
UR - http://www.scopus.com/inward/record.url?scp=0141724627&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0141724627&partnerID=8YFLogxK
U2 - 10.1086/377454
DO - 10.1086/377454
M3 - Article
C2 - 12934181
AN - SCOPUS:0141724627
VL - 188
SP - 661
EP - 665
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
SN - 0022-1899
IS - 5
ER -